De Sousa Rodrigues, Maria Elizabeth
Houser, Madelyn C.
Walker, Douglas I.
Jones, Dean P.
Chang, Jianjun
Barnum, Christopher J.
Tansey, Malú G.
Funding for this research was provided by:
National Institutes of Health (1RF1AG051514, 1RF1AG057247, UL1TR002378)
Article History
Received: 14 May 2019
Accepted: 16 October 2019
First Online: 31 December 2019
Ethics approval and consent to participate
: All experiments were approved by the Institutional Animal Care and Use Committee of Emory University and followed the guidelines established by the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
: All authors have consented to publication.
: MG Tansey is an ex-employee of Xencor, Inc. and is a co-inventor on the dominant-negative TNF patent but does not hold a significant financial stake in Xencor, Inc. or INmune Bio, Inc. CJ Barnum is an employee of INmune Bio. The other authors declare that they have no competing interests.